Previous Page  42 / 64 Next Page
Information
Show Menu
Previous Page 42 / 64 Next Page
Page Background

1ª línea: estudios en marcha

Catalyzes the 

b kd f

NCT03260894

rea own o 

tryptophan to 

kynurenine leading to 

suppression of CTL

1ª lí

Sunitinib o 

pazopanib

and expansion of 

Treg cells

 nea

Random

Pembrolizumab

+

epacadostat

N=630

OP PFS OS

46 pac con C renal; RR 47%

Lara et al; ASCO 2017 #4515